India Ageing and the Longevity Industry
Why in News?
- The Sunday Express Eye cover story of 22 November 2026, titled Chasing Forever, examines how the quest for longevity is moving from laboratories to wellness centres, and warns of risks of unproven treatments.
- According to Grand View Research, India's broad biohacking market was estimated at 1.21 billion dollars in 2025 and is forecast to reach 7.53 billion dollars by 2033.
- The interest comes as India is ageing rapidly: by 2050, people aged 60 and above are expected to be 20.8 per cent of the population, against 8.6 per cent in 2011.
- Experts quoted in the story say many treatments remain experimental, and that longevity medicine runs through concierge clinics and out-of-pocket payments that risk fuelling inequality.
Key Terminologies
- Longevity Science
- The study of ageing and ways to extend healthy lifespan, using ideas such as cellular repair, mitochondrial function, peptides and NAD+ boosters.
- Healthspan
- The number of years a person lives in good health, as distinct from lifespan. The aim of longevity science is to delay disability and dependence, not only death.
- Biohacking
- Self-directed efforts to improve body function through diet, supplements, devices and therapies, which have grown into a commercial market.
- Non-Communicable Diseases
- Long-term diseases such as diabetes and cardiovascular disease that are not passed from person to person, and which often develop earlier in Indians than in Western populations.
Key Issues
- Rapid Ageing: People aged 60 and above are expected to constitute 20.8 per cent of India's population by 2050, compared with 8.6 per cent in 2011, and life expectancy has risen to about 70 years.
- Burden of Non-Communicable Diseases: The country faces a substantial burden of diabetes and cardiovascular disease, which often develop earlier than in Western populations.
- Market for Staying Young: India's biohacking market is estimated at 1.21 billion dollars in 2025 and forecast at 7.53 billion dollars by 2033, with offerings such as hyperbaric oxygen therapy, cryotherapy and plasma exchange.
- Weak Evidence: Dr Prasun Chatterjee says hyperbaric oxygen therapy has clinical uses but no evidence of longevity benefits, and wellness centres offer it as rejuvenation, with risks if used without a clinician.
- Inequality Risk: Professor Deepak Saini of IISc, Bengaluru warns that longevity medicine operates through concierge clinics and expensive diagnostics, and risks building a world where the science of living well fuels inequality.
Key Implications
Positive/Pros/Merits
- Focus on Healthspan: The idea of living healthy for longer can reduce medical bills, spare caregivers and lower dependence, according to Dr Prasun Chatterjee of the Indian Academy of Geriatrics.
- Evidence-Based Lifestyle: Practices such as exercise, diet and sleep, if backed by evidence, can lower the risk of diabetes and heart disease, and are low in cost.
- Research Interest: Growing attention to ageing research can produce useful treatments for diseases of old age.
- Awareness of Ageing: The coverage draws attention to demographic change and the need to plan for a larger elderly population.
Negative/Cons/Demerits
- Unproven Treatments: The story says many treatments remain experimental, with unproven benefits and uncertain long-term safety, so consumers may be exposed to harm and waste.
- Affordability Gap: Expensive private services widen the gap between those who can pay and the majority, while public systems struggle with basic care for the elderly.
- Risk of Overdose and Injury: Without a qualified clinician, therapies such as hyperbaric oxygen can cause ear and sinus injuries, vision changes and, rarely, seizures.
- Misplaced Priorities: A boom in anti-ageing products can divert attention from basic needs such as pensions, primary care and geriatric services.
Key Initiatives
- National Programme for Health Care of the Elderly: A health ministry programme that provides geriatric services at district hospitals and regional geriatric centres.
- Ayushman Vay Vandana: Health cover of Rs 5 lakh for all senior citizens aged 70 and above, announced on 29 October 2024.
- Atal Vayo Abhyuday Yojana: An umbrella scheme of the Ministry of Social Justice and Empowerment for senior citizens, in force from 1 April 2021.
- Maintenance and Welfare of Parents and Senior Citizens Act, 2007: A law that makes it a duty of children and relatives to maintain senior citizens.
Public policy on the elderly focuses on income support, health cover and care services, and the story suggests that the wellness market should not substitute for these basic services.
Director's Perspective
Way Forward
- Invest in primary and geriatric care so that older people get affordable, evidence-based services close to home.
- Regulate wellness and anti-ageing clinics, with clear rules on claims, qualifications and safety.
- Promote preventive health such as screening, nutrition and exercise through public programmes.
- Expand pensions and health insurance for the elderly so that healthy ageing is not limited to the wealthy.
- Fund research on ageing that is open and evidence-based, with results shared for public benefit.
The longevity boom is a sign of a society that is growing older and richer in parts, but its science is uneven and its services are costly. The real challenge for social policy is to ensure that healthy ageing is available to everyone, through primary care, pensions and sound regulation. In a Mains answer, give the 2050 projection, describe the risks of unproven treatments, and conclude that equity and evidence should guide policy on ageing.
GS Relevance
Frequently Asked Questions
How fast is India's population ageing?
People aged 60 and above are expected to constitute 20.8 per cent of India's population by 2050, compared with 8.6 per cent in 2011, according to the figures cited in the Sunday Express story. Life expectancy has risen to about 70 years, while non-communicable diseases such as diabetes and heart disease remain a major burden.
What is the size of India's biohacking market?
According to Grand View Research, India's broad biohacking market was estimated at 1.21 billion dollars in 2025 and is forecast to reach 7.53 billion dollars by 2033. It includes services such as cryotherapy, hyperbaric oxygen therapy and plasma exchange, many of which are sold as anti-ageing treatments.
Why do experts warn about longevity treatments?
Experts quoted in the story say many treatments remain experimental, with unproven benefits and uncertain long-term safety. For example, hyperbaric oxygen therapy has no evidence of longevity benefits, and without a clinician it can cause ear and sinus injuries, vision changes and, rarely, seizures.
PYQ Practice — Statement Analysis
1 People aged 60 and above are expected to be 20.8 per cent of India's population by 2050.
The share was 8.6 per cent in 2011.
2 Healthspan means the number of years a person lives in good health.
Longevity science aims to extend it.
3 The story says hyperbaric oxygen therapy is proven to slow ageing.
Experts say there is no evidence that it offers longevity benefits.
4 Non-communicable diseases such as diabetes and cardiovascular disease are not a concern in India.
They are a substantial burden and often develop earlier than in Western populations.